Benjamin Caleb
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
- Cell Biology top 5%
- Proteoglycans and glycosaminoglycans research
Papers in ⓘ
-
- Cancer therapeutics and mechanisms 2
- DNA Repair Mechanisms 2
- Kruppel-like factors research 1
-
- Proteoglycans and glycosaminoglycans research 3
- Co-authors
- John J. Castellot (5 shared papers)Thomas C. Wright (2 shared papers)Morris J. Karnovsky (2 shared papers)Richard L. Hoover (1 shared paper)Kent Wong (1 shared paper)David F. Albertini (1 shared paper)Brian Herman (1 shared paper)Didier Letourneur (2 shared papers)
- Journals
- Journal of Cellular Physiology (4 papers)Molecular Cancer Therapeutics (2 papers)ACS Medicinal Chemistry Letters (1 paper)PubMed (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Benjamin Caleb
8 papers receiving 807 citations
Peers
Comparison fields: 5 of 74
- Immunology and Allergy 121
- Cell Biology 288
- Cancer Research 149
- Oncology 232
- Molecular Biology 526
Countries citing papers authored by Benjamin Caleb
This map shows the geographic impact of Benjamin Caleb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Caleb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Caleb more than expected).
Fields of papers citing papers by Benjamin Caleb
This network shows the impact of papers produced by Benjamin Caleb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Caleb. The network helps show where Benjamin Caleb may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Caleb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 333 | |
| 2 | 1985 | 259 | |
| 3 | 1990 | 116 | |
| 4 | 1995 | 60 | |
| 5 | 1995 | 26 | |
| 6 | 2020 | 16 | |
| 7 | 1996 | 14 | |
| 8 | Preclinical identification of AZD7762, a novel, potent and selective inhibitor of Checkpoint kinases | 2007 | 3 |
About Benjamin Caleb
Benjamin Caleb is a scholar working on Molecular Biology, Cell Biology, Immunology and Allergy, Cancer Research and Oncology, having authored 8 papers that have together received 827 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), Cancer therapeutics and mechanisms (2 papers), Protease and Inhibitor Mechanisms (2 papers), DNA Repair Mechanisms (2 papers), Cancer Treatment and Pharmacology (1 paper), Kruppel-like factors research (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Immunology and Allergy (121 citations), Cell Biology (288 citations), Cancer Research (149 citations), Oncology (232 citations) and Molecular Biology (526 citations). Benjamin Caleb has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include John J. Castellot, Thomas C. Wright, Morris J. Karnovsky, Richard L. Hoover, Kent Wong, David F. Albertini, Brian Herman, Didier Letourneur, Laurie Pukac and Candice L. Horn. Their work appears in journals such as Journal of Cellular Physiology, Molecular Cancer Therapeutics, ACS Medicinal Chemistry Letters and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.